Recall all batches of MIMPARA 30MG F.C. TABLETS and MIMPARA 60MG F.C. TABLETS

Recall all batches of MIMPARA 30MG F.C. TABLETS and MIMPARA 60MG F.C. TABLETS

2024-07-31

Product Description :

 

 

الاسم التجاري

الاسم العلمي

رقم التسجيل

رقم التشغيلة المتأثرة

الشركة الصانعة

Trade Name

Scientific Name

Register Number

Affected batch number

Manufacturer

MIMPARA 30MG F.C. TABLETS

CINACALCET 30 MG

13-475-08

جميع التشغيلات

PATHEON

MIMPARA 60MG F.C. TABLETS

CINACALCET 60MG

14-475-08

Issue :

SFDA has issued a recall all batches of MIMPARA 30MG F.C. tablets and MIMPARA 60MG F.C. products due to the affected batches are not comply with the required specifications. AMGEN EUROPE B.V. is voluntarily recalling all batches of the above products.

Recommendations :

For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.

For patients,

  1. Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
  2. Contact the recalling firm or SFDA if you have any questions about the recall.
  3. Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).


Recall all batches of MIMPARA 30MG F.C. TABLETS and MIMPARA 60MG F.C. TABLETS